Trademark Details For ELDERBERRY D3FENSE (Serial Number 90595886)

  •  Home
  •  Print
ELDERBERRY D3FENSE
1
1
1
0
Serial Number  United States - USPTO 90595886
Registration Number 6810212
Mark
ELDERBERRY D3FENSE
Filing Date Mar-23-2021
Status
Registered  
REGISTERED (700)
REGISTERED
Attorney Name
TTAB
0
Action Tags
  



  • Disclaimer:

005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: Jan-31-2012

First Use in Commerce: Jan-31-2012





Correspondences

NameMarc Phillip Bodner
Address920 EAST 17TH STREET, SUITE 116 BROOKLYN, NY 11230

Prosecution History

  
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Mar-26-2021NEW APPLICATION ENTERED IN TRAM   NWAPI
Jun-26-2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM   NWOSI
Oct-28-2021ASSIGNED TO EXAMINER   DOCKD
Nov-02-2021
NON-FINAL ACTION WRITTEN
  
CNRTR
Nov-02-2021NON-FINAL ACTION E-MAILED   GNRTF
Nov-02-2021
NOTIFICATION OF NON-FINAL ACTION E-MAILED
  
GNRNO
Nov-02-2021EXAMINERS AMENDMENT -WRITTEN   CNEAR
Nov-02-2021
EXAMINERS AMENDMENT E-MAILED
  
GNEAO
Nov-02-2021
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  
GNENO
Nov-02-2021EXAMINER'S AMENDMENT ENTERED   XAECI
Nov-02-2021APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Nov-17-2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Dec-07-2021PUBLISHED FOR OPPOSITION   PUBOA
Dec-07-2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Feb-01-2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
May-11-2022TEAS STATEMENT OF USE RECEIVED   EISUI
May-24-2022CASE ASSIGNED TO INTENT TO USE PARALEGAL   AITUA
May-11-2022USE AMENDMENT FILED   IUAFS
Jun-01-2022STATEMENT OF USE PROCESSING COMPLETE   SUPCI
Jun-30-2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED   CNPRP
Jul-01-2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED   SUNAE
Aug-02-2022REGISTERED-PRINCIPAL REGISTER   R.PRA
Aug-02-2022NOTICE OF REGISTRATION CONFIRMATION EMAILED   NRCCE